Pratt C M, Camm A J, Bigger J T, Breithardt G, Campbell R W, Epstein A E, Kappenberger L J, Kuck K, Pocock S, Saksena S, Waldo A L
Baylor College of Medicine, Houston, Texas 77030, USA.
Eur Heart J. 1999 Nov;20(21):1538-52. doi: 10.1053/euhj.1999.1850.
A report from a Study group, proposed by A. J. Camm, London, of the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology; co-sponsored by the North American Society of Pacing and Electrophysiology. The Study Group was convened on 29 August 1997 at Saltsjöbaden, near Stockholm. The meeting was chaired by A. J. Camm, London, and C. M. Pratt, Houston. Based on the presentation and discussions, a first draft of the documents was prepared by C. Pratt and J. Camm which was then circulated to all members three times for their review. All members of the Study Group approved the final manuscript. This report represents the opinion of the members of this Study Group and does not necessarily reflect the official position of either society.The meeting of the Study Group was made possible by unrestricted educational grants from Medtronic, Guidant, Proctor & Gamble, Berlex and Sanofi.Also, presented, in part, at the Cardio-Renal Drugs Advisory Board meeting of the Food and Drug Administration, Bethesda, Maryland, on 30 April 1999.
一份研究小组的报告，由伦敦的A. J. 卡姆提议，欧洲心脏病学会心律失常与心脏起搏工作组发布；由北美心脏起搏与电生理学会共同发起。该研究小组于1997年8月29日在斯德哥尔摩附近的萨尔茨约巴登召开会议。会议由伦敦的A. J. 卡姆和休斯顿的C. M. 普拉特主持。基于会上的报告和讨论，由C. 普拉特和J. 卡姆起草了文件初稿，随后分三次分发给所有成员以供审阅。研究小组的所有成员均批准了最终稿件。本报告代表了该研究小组成员的意见，不一定反映任何一个学会的官方立场。研究小组会议的召开得益于美敦力公司、吉德公司、宝洁公司、勃林格殷格翰公司和赛诺菲公司提供的无限制教育资助。此外，部分内容曾于1999年4月30日在马里兰州贝塞斯达的美国食品药品监督管理局心脏-肾脏药物咨询委员会会议上展示。
